Recent Finacing
Recent Raise
Amicus Therapeutics develops treatments for genetic diseases using its CHART platform, advancing therapies for Fabry, Pompe and other lysosomal storage disorders.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Amicus Therapeutics.
